Point72 Asset Management’s Foghorn Therapeutics FHTX Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $3.14M | Buy |
668,719
+43,502
| +7% | +$204K | 0.01% | 772 |
|
|
2025
Q1 | $2.28M | Sell |
625,217
-9,544
| -2% | -$34.8K | 0.01% | 784 |
|
|
2024
Q4 | $3M | Buy |
634,761
+235,059
| +59% | +$1.11M | 0.01% | 737 |
|
|
2024
Q3 | $3.72M | Sell |
399,702
-6,939
| -2% | -$64.6K | 0.01% | 652 |
|
|
2024
Q2 | $2.34M | Sell |
406,641
-30,728
| -7% | -$177K | 0.01% | 733 |
|
|
2024
Q1 | $2.93M | Sell |
437,369
-102,631
| -19% | -$689K | 0.01% | 813 |
|
|
2023
Q4 | $3.48M | Buy |
540,000
+255,145
| +90% | +$1.65M | 0.01% | 786 |
|
|
2023
Q3 | $1.42M | Buy |
284,855
+5,700
| +2% | +$28.5K | ﹤0.01% | 867 |
|
|
2023
Q2 | $1.97M | Buy |
+279,155
| New | +$1.97M | 0.01% | 807 |
|
|
2023
Q1 | – | Sell |
-33,000
| Closed | -$211K | – | 1790 |
|
|
2022
Q4 | $211K | Sell |
33,000
-355,600
| -92% | -$2.27M | ﹤0.01% | 901 |
|
|
2022
Q3 | $3.33M | Buy |
388,600
+12,600
| +3% | +$108K | 0.01% | 703 |
|
|
2022
Q2 | $5.11M | Buy |
376,000
+370,800
| +7,131% | +$5.04M | 0.02% | 603 |
|
|
2022
Q1 | $79K | Sell |
5,200
-378,272
| -99% | -$5.75M | ﹤0.01% | 976 |
|
|
2021
Q4 | $8.77M | Buy |
+383,472
| New | +$8.77M | 0.04% | 520 |
|
|
2021
Q2 | – | Sell |
-109,200
| Closed | -$1.44M | – | 977 |
|
|
2021
Q1 | $1.44M | Buy |
+109,200
| New | +$1.44M | 0.01% | 719 |
|